Literature DB >> 6903794

Toward an epidemiology of work disability.

E Yelin, M Nevitt, W Epstein.   

Abstract

The indirect cost of illness due to lost wages exceeds the cost of medical services by a large margin. Social characteristics of persons with physical impairment are more important than the characteristics of their medical condition in predicting whether disability will lead to work loss. Public policy toward disability currently emphasizes the "human capital" with which persons with impairments confront the labor market; this study suggests a new emphasis on social characteristics of the workplace.

Entities:  

Mesh:

Year:  1980        PMID: 6903794

Source DB:  PubMed          Journal:  Milbank Mem Fund Q Health Soc        ISSN: 0160-1997


  5 in total

1.  Health-related quality of life and employment among persons with systemic lupus erythematosus.

Authors:  Jinoos Yazdany; Edward Yelin
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

2.  Work loss and work entry among persons with systemic lupus erythematosus: comparisons with a national matched sample.

Authors:  Edward Yelin; Chris Tonner; Laura Trupin; Pantelis Panopalis; Jinoos Yazdany; Laura Julian; Patricia Katz; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2009-02-15

3.  Epidemiology of musculoskeletal impairments and associated disability.

Authors:  L S Cunningham; J L Kelsey
Journal:  Am J Public Health       Date:  1984-06       Impact factor: 9.308

4.  Return to work following injury: the role of economic, social, and job-related factors.

Authors:  E J MacKenzie; J A Morris; G J Jurkovich; Y Yasui; B M Cushing; A R Burgess; B J DeLateur; M P McAndrew; M F Swiontkowski
Journal:  Am J Public Health       Date:  1998-11       Impact factor: 9.308

5.  Not better but quite good: effects on work loss of combination treatment for rheumatoid arthritis with and without biological agents.

Authors:  Edward Yelin
Journal:  JAMA Intern Med       Date:  2013-08-12       Impact factor: 21.873

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.